- Intratumoral DNA-based delivery of checkpoint-inhibiting antibodies and interleukin 12 triggers T cell infiltration and anti-tumor response(2022)
Auteurs: Liesl Jacobs, Lidia Yshii, Steffie Junius, Nick Geukens, Adrian Liston, Paul Declerck
Pagina's: 984 - 992
- Intratumoral gene transfer of immunomodulatory antibody combinations: a preclinical proof-of-concept study(2021)
Auteurs: Liesl Jacobs, Paul Declerck, Adrian Liston, Kevin Hollevoet
- Electroporation outperforms in vivo-jetPEI for intratumoral DNA-based reporter gene transfer(2020)
Auteurs: Liesl Jacobs, Nick Geukens, Paul Declerck, Kevin Hollevoet
- Building a Versatile and Clinically Translatable Platform for DNA-Based Antibody Therapeutics(2020)
Auteurs: Kevin Hollevoet, Elien De Smidt, Giles Vermeire, Liesl Jacobs, Stephanie De Vleeschauwer, Nick Geukens, Paul Declerck
Pagina's: 237 - 238
- DNA-Based Delivery of Checkpoint Inhibitors in Muscle and Tumor Enables Long-Term Responses with Distinct Exposure(2020)
Auteurs: Liesl Jacobs, Nick Geukens, Paul Declerck, Kevin Hollevoet
Pagina's: 1068 - 1077
